期刊文献+

犬乳腺肿瘤细胞系的生物学特性及p53因子表达分析 被引量:2

Biological characterization and analysis the expression of p53 in cell lines of the canine mammary gland tumor
在线阅读 下载PDF
导出
摘要 为筛选p53肿瘤因子表达更强的犬乳腺肿瘤细胞系,从而为乳腺肿瘤相关因子和转移机制的实验研究选择更敏感的细胞系,本实验采用由自然发生乳腺肿瘤病例的原发病灶和转移病灶分离培养的4种细胞(CHMp、CHMm、CIPp和CIPm),选取经传代120代后、生长性状稳定的细胞系作为研究对象,对不同细胞系的性状进行分析,同时利用p53抗体对犬乳腺肿瘤细胞系进行免疫组织化学检测。结果显示:通过消化法培养的细胞,其生长曲线呈"S"型,倍增时间分别为21.3 h、35.3 h、42.3 h和49.1 h;采用MTT检测和软琼脂培养比较分析表明CHMp、CHMm的细胞活力和增殖能力均强于CIPp、CIPm;抗体检测显示,p53抗体在CHMp、CHMm中表达强于CIPp、CIPm,在活性和增殖能力最弱的CIPm细胞中表达强度最弱(p<0.01)。实验结果表明,不同来源的细胞系生物学特性差异较大,在研究乳腺肿瘤相关因子和转移机制的实验中选用CHMp和CHMm细胞系敏感性更高,实验效果会更明显。 To screen the higher level of tumor factors p53 and sensitive cell line for the study of the metastatic mechanism in canine breast tumor, we established 4 cell lines (CHMp, CHMm, CIPp and CIPm) derived from primary lesions as well as derived from the metastatic lesions through primary cultures of tissue from a dog. Then we characterized the cancer cells. The result showed that the growth curve shown "S" shape accorded with the digestion method in different period. MTT assay and soft agar-agar culture demonstrated that the cell proliferation and vigor of CHMp and CHMm were high compared with the other two groups; Immunohistochemical technique showed the expression of p53 in CHMp and CHMm were higher than that of CIPp and CIPm. The cell proliferation and vigor of CIPm was the weakest (p〈0.01). The results demonstrated that tumor cell lines deriving from different tissues have significantly biological characteristics. The cell line of mammary gland tumor CHMp and CHMm have higher sensitivity in the study of mammary gland tumor and metastasis.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2014年第6期444-447,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 国家自然科学基金(31372492)
关键词 犬乳腺肿瘤 细胞系 p53因子 生物学特性 canine breast tumor cell line p53 factors biological characteristics
  • 相关文献

参考文献11

  • 1Zamani-Ahmadmahmudi M, Nassiri S M, Jahanzad I, et al.Isolation and characterization of a canine mammary cell line prepared for proteomics analysis [J].Tissue Cell, 2013, 45(3): 183-190.
  • 2Lee Jia-lin, Chang Ching-jin, Wu Su-ying, et al.Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands [J].Breast Cancer Res Treat, 2004, 84: 139-149.
  • 3Boggs R M, Wright Z M, Stickney M J, et al.MicroRNA expression in canine mammary cancer [J].Mamm Genome, 2008, 19: 561-569.
  • 4Carvalho M I, Guimaraes M J, Pires I, et al.EGFR and microvessel density in canine malignant mammary tumours [J].Res Vet Sci, 2013, 95(3): 1094-1099.
  • 5Zamani-Ahmadmahmudi M, Nassiri S M, Rahbarghazi R.Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts [J].Electrophoresis, 2014, 35(6): 901-910.
  • 6Król M, Majchrzak K, Mucha J, et al.CSF-1R as an inhibitor of apoptosis and promoter of proliferation, migration and invasion of canine mammary cancer cells [J].BMC Vet Res, 2013, 9: 65.
  • 7Nakagawa T, Uyama R, Ohashi E, et al.The expression of sialyl Lewis X in canine and feline mammary gland tumors [J].J Vet Med Sci, 2002, 64(10): 949-952.
  • 8李文通,周庚寅,宋现让,迟伟玲,任瑞美,王兴武.MCF-7/BCRP细胞系的建立及其生物学特征[J].山东大学学报(医学版),2005,43(6):469-472. 被引量:3
  • 9任乐荣,刘玉琴,李正江,苏小玲,顾蓓,董继红.人喉癌细胞系的建立及生物学特性研究[J].首都医科大学学报,2006,27(5):612-615. 被引量:3
  • 10赵婷婷,张宁宁,何倩婷,丁学强,刘中华,王安训.线粒体肿瘤抑制基因1在舌鳞状细胞癌组织中的表达及意义[J].中华口腔医学研究杂志(电子版),2014,8(1):10-13. 被引量:1

二级参考文献29

  • 1Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells[J]. Proc Natl Acad Sci USA, 1998, 95(26):15 665~15 670.
  • 2Robert W Robey, Yasumasa Honjo, Anne van de Laar,et al. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2) [J].Biochem et Biophys Acta, 2001, 1512: 171~182.
  • 3Ross DD, Yang W, Abruzzo LV, et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines [J]. J Natl Cancer Inst, 1999, 91: 429~433.
  • 4Xu J, Liu Y, Yang Y, et al. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2 [J]. J Biol Chem, 2004, 279:19 781~19 789.
  • 5Sridhar K Rabindran, Douglas D Ross, L Austin Doyle,et al. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein1 [J]. Cancer Res, 2000, 60: 47~50.
  • 6Allen JD, van Loevezijn A, Lakhai JM, et al. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C [J]. Mol Cancer Ther, 2002, 1: 417~425.
  • 7Abbott BL, Colapietro AM, Barnes Y, et al. Low levels of ABCG2 expression in adult AML blast samples [J].Blood, 2002, 100:4 594~4 601.
  • 8Kowalski P, Stein U, Scheffer GL, et al. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2 [J]. Cancer Gene Ther, 2002, 9:579~586.
  • 9Freshney R I.Primary culture of animal cells:a manual of basic technique[M].4th ed.New York:Wiley,2000:180-207.
  • 10Moore A E,Sabachewsky L,Toolan H W.Culture characteristics of four permanent lines of human cancer cells[J].Cancer Res,1955,15:598-602.

共引文献4

同被引文献13

  • 1Steck P A, Pershouse M A, Jasser S A, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J].Nat Genet, 1997, 15(4): 356-362.
  • 2Lopez-knowles E, O’Toole S A, McNeil C M, et al. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality [J].Int J Cancer, 2010, 126(5): 1121-1131.
  • 3Masliah-Planchon J, Pasmant E, Luscan A, et al. MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigensis [J].BMC Genomics, 2013, 14: 473.
  • 4John J K, Paraiso K H, Rebecca V W, et al. GSK3β inhibition blocks melanoma cell/host interactions by down-regulating N-cadherin expression and decreasing FAK phosphorylation [J].Invest Dermatol, 2012, 132(12): 2818-2827.
  • 5Qiu Chang-wei, Lin De-gui, Wang Jin-qiu, et al. Expression and significance of PTEN in canine mammary gland tumours [J].Res Vet Sci, 2008, 383-388.
  • 6Esteva F J, Guo Hua, Zhang Si-yuan, et al. PTEN, PIK3CA, p-Akt, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer [J].Am J pathol, 2010, 177(4): 1647-1656.
  • 7Roy S, Yu Ying-jie, Padhye S B, et al. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down- regulating miR-21 [J].PLoS One, 2013, 8(7): 21-29.
  • 8Goo C K, Lim H Y, Ho Q S, et al. PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1 [J].PLoS One, 2012, 7(9): e45806.
  • 9Carvalho S, Schmitt F. Potential role of PI3K inhibitors in the treatment of breast cance [J].Future Oncol, 2010, 6(8): 1251-1263.
  • 10Cristina M D, Lucia C, Xabier A, et al. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation [J].Leuk Res, 2008, 32(5): 709-716.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部